✦ LIBER ✦

W1126 Cost-Effectiveness of Natalizumab in Crohn's Disease Patients Who Have Failed Anti-TNF Alpha Therapy

✍ Scribed by Sands, Bruce E.; Wolf, Douglas C.; Panjabi, Sumeet; Niecko, Timothy; Hass, Steven; Lacey, Loretto; Spencer, Mike

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PGI5 COST-EFFECTIVENESS OF NATALIZUMAB I

✍ S Panjabi; T Niecko; SL Hass; L Lacey; MD Spencer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Cost-Effectiveness of Third-Line Anti-TN

✍ Ananthakrishnan, Ashwin N. ;Hur, Chin ;Korzenik, Joshua R. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

P.06.12 NUTRITIONAL EFFECTS OF ANTI-TNF-

✍ S. Mazzuoli; I. Addante; S. Fragnan; N. Regano; M. Rizzi; G. Leogrande; A. Di Mo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

P530 Effectiveness of anti-TNF drugs in

✍ R-Grau, M.; Chaparro, M.; Mesonero, F.; Barreiro-de Acosta, M.; Castro, L.; Vera 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 70 KB

Cost-Effectiveness Analysis of Biologica

✍ Ryazhenov, V.V.; Emchenko, I.V. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

W1320 Natalizumab is Effective in the Tr

✍ Elvanides, Harry S.; Burchett, Mary; Ingram, Karen R.; Annis, Kim; Arsenescu, Ra 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB